Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Fargion

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Hepatology (Baltimore, Md.)|August 13, 2011
Patatin-like phospholipase domain containing-3 Ile148Met and fibrosis progression after liver transplantationLuca Valenti, Silvia Fargion
Journal of Hepatology|September 16, 2003
Prevalence of hepatitis C virus infection in porphyria cutanea tardaSilvia Fargion, Anna Ludovica Fracanzani
The New England Journal of Medicine|July 24, 2010
Apolipoprotein C3 gene variants in nonalcoholic fatty liver diseaseLuca Valenti, Valerio Nobili, Silvia Fargion
International Journal of Molecular Sciences|April 15, 2016
Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLDRosa Lombardi, Giuseppina Pisano, Silvia Fargion
World Journal of Gastroenterology|August 10, 2012
Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver diseaseLuca Valenti, Paola Dongiovanni, Silvia Fargion
Journal of Hepatology|November 22, 2011
Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis CLuca Valenti, Massimo Colombo, Silvia Fargion
Seminars in Immunopathology|May 15, 2009
The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?Luca Valenti, Anna Ludovica Fracanzani, Silvia Fargion
Current Pharmaceutical Design|November 23, 2019
Combined use of Genetic Polymorphisms and Elastographic Techniques in NAFLD: Fact or Fiction?Rosa Lombardi, Silvia Fargion, Anna L Fracanzani
Hepatology (Baltimore, Md.)|April 8, 2010
Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overloadSilvia Fargion, Luca Valenti, Anna Ludovica Fracanzani
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2010
Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseasesSilvia Fargion, Luca Valenti, Anna Ludovica Fracanzani
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|August 13, 2011
Patatin-like phospholipase domain containing-3 Ile148Met and fibrosis progression after liver transplantationLuca Valenti, Silvia Fargion
Journal of Hepatology|September 16, 2003
Prevalence of hepatitis C virus infection in porphyria cutanea tardaSilvia Fargion, Anna Ludovica Fracanzani
The New England Journal of Medicine|July 24, 2010
Apolipoprotein C3 gene variants in nonalcoholic fatty liver diseaseLuca Valenti, Valerio Nobili, Silvia Fargion
International Journal of Molecular Sciences|April 15, 2016
Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLDRosa Lombardi, Giuseppina Pisano, Silvia Fargion
World Journal of Gastroenterology|August 10, 2012
Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver diseaseLuca Valenti, Paola Dongiovanni, Silvia Fargion
Journal of Hepatology|November 22, 2011
Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis CLuca Valenti, Massimo Colombo, Silvia Fargion
Seminars in Immunopathology|May 15, 2009
The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?Luca Valenti, Anna Ludovica Fracanzani, Silvia Fargion
Current Pharmaceutical Design|November 23, 2019
Combined use of Genetic Polymorphisms and Elastographic Techniques in NAFLD: Fact or Fiction?Rosa Lombardi, Silvia Fargion, Anna L Fracanzani
Hepatology (Baltimore, Md.)|April 8, 2010
Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overloadSilvia Fargion, Luca Valenti, Anna Ludovica Fracanzani
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2010
Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseasesSilvia Fargion, Luca Valenti, Anna Ludovica Fracanzani
Pageof 16